Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
J Clin Exp Hematop ; 59(4): 196-201, 2019.
Artigo em Inglês | MEDLINE | ID: mdl-31866621

RESUMO

Gamma heavy chain disease (γ-HCD) is a rare B-cell neoplasm that produces a truncated immunoglobulin γ-heavy chain lacking the light chain. The clinical features of γ-HCD are heterogeneous, resembling different types of B-cell lymphomas. Although rheumatoid arthritis (RA) is one of the common underlying diseases of γ-HCD, the therapeutic modality for RA has changed greatly in recent years; therefore, γ-HCD as iatrogenic immunodeficiency-associated lymphoproliferative disorder (LPD) should be taken into consideration. Here, we report such a γ-HCD case. A 69-year-old female was admitted because of fever, multiple lymph node swelling in the abdominal cavity, and peritoneal effusion. She had been treated using methotrexate for RA for 14 years, and using infliximab and adalimumab for Crohn's disease for one year. The serum concentration of IgG was 3,525 mg/dL, which was revealed to be monoclonal IgG lacking the light chain by rocket immunoselection assay. CD19+/CD20-/smκ-/smλ- large abnormal lymphocytes were observed in the peritoneal fluid, which were demonstrated to be clonal B-cells by PCR examination. Discontinuation of methotrexate did not improve her condition and she died of pneumonia. Many abnormal lymphocytes positive for IgG and EBER but negative for the light chain were found on immunohistological examination of necropsy specimens from the spleen and bone marrow.


Assuntos
Artrite Reumatoide , Neoplasias Hematológicas , Cadeias gama de Imunoglobulina/metabolismo , Síndromes de Imunodeficiência , Linfoma de Células B , Metotrexato/efeitos adversos , Proteínas de Neoplasias/metabolismo , Adalimumab/administração & dosagem , Adalimumab/efeitos adversos , Artrite Reumatoide/tratamento farmacológico , Artrite Reumatoide/metabolismo , Artrite Reumatoide/patologia , Doença de Crohn/tratamento farmacológico , Doença de Crohn/metabolismo , Doença de Crohn/patologia , Evolução Fatal , Feminino , Neoplasias Hematológicas/induzido quimicamente , Neoplasias Hematológicas/metabolismo , Neoplasias Hematológicas/patologia , Humanos , Síndromes de Imunodeficiência/induzido quimicamente , Síndromes de Imunodeficiência/metabolismo , Síndromes de Imunodeficiência/patologia , Infliximab/administração & dosagem , Infliximab/efeitos adversos , Linfoma de Células B/induzido quimicamente , Linfoma de Células B/metabolismo , Linfoma de Células B/patologia , Metotrexato/administração & dosagem , Pessoa de Meia-Idade
2.
Rinsho Byori ; 51(10): 974-7, 2003 Oct.
Artigo em Japonês | MEDLINE | ID: mdl-14653196

RESUMO

Celiac disease is a permanent intolerance to ingested gluten that results in immunologically mediated inflammatory damage of the small intestinal mucosa. Here we report the case of a patient with Celiac disease demonstrating simultaneous macroamylasemia and macrolipasemia. The patient showed persistently elevated levels of serum amylase and lipase. Amylase and lipase in normal serum were eluted from a Superdex-200 column after the 4S protein. These enzymes in the serum from this patient were eluted in the 19S protein. This finding indicated that these enzymes from this patient had a molecular weight greater than that of normal amylase and lipase. Immunoprecipitation assay showed that amylase was bound to polyclonal IgG and IgA, whereas lipase was bound to polyclonal IgA. To our knowledge, the simultaneous presence of macroamylase and macrolipase in the same patient has been previously reported in only four cases. Interestingly, two of those patients had Celiac disease. If macroamylase and macrolipase are present, the possibility of Celiac disease should be considered.


Assuntos
Amilases/sangue , Doença Celíaca/diagnóstico , Lipase/sangue , Idoso , Amilases/metabolismo , Biomarcadores/sangue , Doença Celíaca/etiologia , Feminino , Humanos , Imunoglobulina A/sangue , Imunoglobulina A/metabolismo , Imunoglobulina G/sangue , Imunoglobulina G/metabolismo , Lipase/metabolismo , Peso Molecular , Testes de Precipitina , Ligação Proteica
3.
Rinsho Byori ; 51(9): 847-51, 2003 Sep.
Artigo em Japonês | MEDLINE | ID: mdl-14560651

RESUMO

We report a case of mu-heavy chain disease. A 56-year-old woman presented with anemia and hemorrhagic diathesis. The serum of the patient was found to have free mu-heavy chain. The patient also had a kappa type-Bence Jones protein in serum and urine. Immunoelectrophoresis showed an abnormal precipitin line in the alpha 2-globulin region which reacted with antiserum to mu-chain but not with antiserum for light chains. The molecular weight of the monomer of the patient's mu-heavy chain protein was approximately 67,000 daltons less than that of the normal mu-heavy chain protein.


Assuntos
Doença das Cadeias Pesadas/imunologia , Cadeias mu de Imunoglobulina/imunologia , Proteína de Bence Jones/metabolismo , Feminino , Doença das Cadeias Pesadas/diagnóstico , Humanos , Cadeias mu de Imunoglobulina/sangue , Pessoa de Meia-Idade
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...